You Prefer Flexible Medication Options Mochi lets you choose compounded GLP-1s, compounded GLP-1/GIP, or brand-name meds if covered by insurancemore flexibility than most competitors
"Over the past decade, the results of cardiovascular outcomes trials such as SUSTAIN 6 have fundamentally changed the management of diabetes, as they have demonstrated that therapies like semaglutide can meaningfully reduce the risk of major cardiovascular events, including heart attacks and non-fatal strokes, in people living with type 2 diabetes with, or at high risk of, cardiovascular disease
However, its important to discuss your suitability for Semaglutide with your healthcare provider and to follow the recommended dosing schedule and healthy lifestyle habits
Evidence from bariatric and obesity medicine programs consistently shows that patients do better when they have support from family and friends, and from a multidisciplinary clinical team that provides ongoing follow-up and individualized care